MERTK and atherosclerosis: During atherosclerosis, oxidative stress can lead to ADAM17 production and proteolytic cleavage of MerTK, generating a soluble form that acts as a decoy receptor for the MerTK ligand GAS6 and thereby blocking efferocytosis [63, 64].